Glency Sue Marie Senires Corominas, MD
Family Practice · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 058189 · California Pacific Medical Ctr-Davies Campus Hosp · Providence Santa Rosa Memorial Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Corominas’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A158545 · Current
Licensed to practise in California · since 2018 · expires 2028-09-30 · Cebu Institute of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$78,972
Medicare paid this office $78,972 for 310 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 153 | $22,125 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 113 | $15,938 | $141 |
| Short return visit (20+ min) | 135 | $9,781 | $62 |
| Sarscov2 vac 50 mcg/0.5ml im | 33 | $5,124 | $151 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,071 | $291 |
See all 13 services
| Return visit (30+ min) | 153 | $22,125 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 113 | $15,938 | $141 |
| Short return visit (20+ min) | 135 | $9,781 | $62 |
| Sarscov2 vac 50 mcg/0.5ml im | 33 | $5,124 | $151 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $4,071 | $291 |
| Long return visit (40+ min) | 24 | $3,919 | $131 |
| Influenza vaccine, inactivated | 33 | $2,700 | $82 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $1,959 | $178 |
| Admn sarscov2 vacc 1 dose | 33 | $1,593 | $47 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 72 | $1,214 | $13 |
| Administration of influenza virus vaccine | 33 | $1,195 | $35 |
| Annual depression screening, 5 to 15 minutes | 30 | $640 | $21 |
| Administration of pneumococcal vaccine | 15 | $527 | $35 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
310 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 8% · Women 77% · Also on Medicaid 9% · Health risk score 0.81. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 57% · Diabetes 17% · Depression 15% · Coronary heart disease 14% · Chronic kidney disease 14% · Cancer 13% · Atrial fibrillation 13% · Heart failure 7% · COPD 6% · Stroke 5%.
The office billed $255,486, Medicare allowed $99,562 and paid $78,972; for 1,591 services of 55 kinds; $13,151 of it was for drugs given in the office and $65,821 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 310 | 1,591 | 74 | 0.81 | $255,486 | $78,972 |
| 2023 | 260 | 683 | 74 | 0.81 | $170,584 | $59,332 |
| 2022 | 343 | 910 | 74 | 0.83 | $221,029 | $74,132 |
| 2021 | 292 | 825 | 73 | 0.86 | $189,292 | $64,751 |
| 2020 | 310 | 812 | 72 | 1.00 | $161,378 | $50,105 |
| 2019 | 55 | 119 | 73 | 0.97 | $22,570 | $7,360 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 107 | $15,533 | $102 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 93 | $13,362 | $144 |
| Short return visit (20+ min) | 111 | $8,924 | $72 |
| Long return visit (40+ min) | 29 | $4,781 | $149 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 43 | $3,260 | $76 |
| Administration of influenza virus vaccine | 37 | $1,264 | $34 |
| Administration of pneumococcal vaccine | 18 | $618 | $34 |
| Annual depression screening, 5 to 15 minutes | 26 | $554 | $21 |
2022: 11 services
| Return visit (30+ min) | 171 | $22,397 | $95 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 123 | $17,842 | $145 |
| Short return visit (20+ min) | 161 | $12,790 | $64 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 44 | $3,091 | $70 |
| Long return visit (40+ min) | 14 | $2,336 | $123 |
| Pneumococcal vaccine, 23-valent | 15 | $1,982 | $132 |
| Administration of influenza virus vaccine | 46 | $1,574 | $33 |
| Administration of pneumococcal vaccine | 27 | $910 | $34 |
| Annual depression screening, 5 to 15 minutes | 25 | $522 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $153 | $10 |
| Automated urinalysis test | 12 | $31 | $2 |
2021: 10 services
| Return visit (30+ min) | 125 | $17,819 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 113 | $16,329 | $145 |
| Short return visit (20+ min) | 154 | $13,995 | $65 |
| Long return visit (40+ min) | 19 | $3,306 | $157 |
| Pneumococcal vaccine, 23-valent | 21 | $2,620 | $125 |
| Influenza vaccine split virus, preservative free | 36 | $2,345 | $65 |
| Administration of influenza virus vaccine | 42 | $794 | $19 |
| Administration of pneumococcal vaccine | 22 | $414 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $261 | $12 |
| Automated urinalysis test | 13 | $29 | $2 |
2020: 11 services
| Return visit (30+ min) | 134 | $12,476 | $80 |
| Short return visit (20+ min) | 176 | $12,302 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 64 | $8,020 | $125 |
| Pneumococcal vaccine, 13-valent | 15 | $3,373 | $225 |
| Influenza vaccine split virus, preservative free | 50 | $3,049 | $61 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,586 | $88 |
| Pneumococcal vaccine, 23-valent | 12 | $1,431 | $119 |
| Administration of influenza virus vaccine | 54 | $972 | $18 |
| Short return visit | 20 | $593 | $27 |
| Administration of pneumococcal vaccine | 27 | $476 | $18 |
| Automated urinalysis test | 12 | $29 | $2 |
2019: 4 services
| Short return visit (20+ min) | 30 | $2,132 | $63 |
| Return visit (30+ min) | 15 | $1,282 | $85 |
| Influenza vaccine split virus, preservative free | 11 | $593 | $54 |
| Administration of influenza virus vaccine | 12 | $208 | $17 |
Drugs they prescribed that Part D paid
$335,278
Pharmacies billed $335,278 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (226 of 4,339) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 6% of their opioid prescriptions.
3,871 generic and 447 brand-name prescriptions · $335,278 in drug cost · 99 antibiotic prescriptions to 70 people · 30 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 41 | $46,409 | $1,132 |
| Trelegy Ellipta | 21 | $23,795 | $1,133 |
| Eliquis | 28 | $21,143 | $755 |
| Wegovy | 16 | $20,954 | $1,310 |
| Mounjaro | 14 | $20,878 | $1,491 |
See all 89 drugs
| Ozempic | 41 | $46,409 | $1,132 |
| Trelegy Ellipta | 21 | $23,795 | $1,133 |
| Eliquis | 28 | $21,143 | $755 |
| Wegovy | 16 | $20,954 | $1,310 |
| Mounjaro | 14 | $20,878 | $1,491 |
| Myrbetriq | 12 | $10,727 | $894 |
| Atorvastatin | 327 | $4,667 | $14 |
| Levothyroxine | 231 | $3,170 | $14 |
| Losartan | 140 | $3,010 | $22 |
| Budesonide-Formoterol | 12 | $2,833 | $236 |
| Hydrocodone-Acetaminophen | 118 | $2,826 | $24 |
| Duloxetine | 50 | $2,659 | $53 |
| Rosuvastatin | 49 | $2,367 | $48 |
| Albuterol Sulfate Hfa | 72 | $2,295 | $32 |
| Gabapentin | 165 | $2,158 | $13 |
| Trazodone | 120 | $1,745 | $15 |
| Quetiapine | 12 | $1,711 | $143 |
| Estradiol | 31 | $1,663 | $54 |
| Celecoxib | 42 | $1,642 | $39 |
| Synthroid | 21 | $1,598 | $76 |
| Famotidine | 19 | $1,483 | $78 |
| Bupropion Xl | 38 | $1,384 | $36 |
| Metformin Hcl Er | 91 | $1,383 | $15 |
| Tamsulosin | 58 | $1,283 | $22 |
| Calcitonin-Salmon | 22 | $1,263 | $57 |
| Venlafaxine Hcl Er | 34 | $1,189 | $35 |
| Oxycodone-Acetaminophen | 55 | $1,168 | $21 |
| Lisinopril | 102 | $1,019 | $10 |
| Budesonide Ec | 11 | $1,011 | $92 |
| Esomeprazole Magnesium | 13 | $838 | $64 |
| Valacyclovir | 37 | $837 | $23 |
| Simvastatin | 70 | $790 | $11 |
| Amlodipine Besylate | 148 | $786 | $5 |
| Montelukast | 40 | $743 | $19 |
| Dextroamphetamine-Amphet Er | 13 | $712 | $55 |
| Ropinirole | 12 | $705 | $59 |
| Pantoprazole | 34 | $640 | $19 |
| Liothyronine | 23 | $624 | $27 |
| Sertraline | 57 | $612 | $11 |
| Escitalopram | 42 | $583 | $14 |
| Allopurinol | 49 | $572 | $12 |
| Buspirone | 46 | $569 | $12 |
| Fluticasone Propionate | 32 | $518 | $16 |
| Omeprazole | 49 | $503 | $10 |
| Metoprolol | 39 | $493 | $13 |
| Mirtazapine | 38 | $480 | $13 |
| Hydrochlorothiazide | 64 | $475 | $7 |
| Ondansetron Odt | 19 | $445 | $23 |
| Losartan-Hydrochlorothiazide | 23 | $429 | $19 |
| Alendronate | 34 | $426 | $13 |
| Lamotrigine | 16 | $407 | $25 |
| Pregabalin | 13 | $394 | $30 |
| Alprazolam | 50 | $386 | $8 |
| Citalopram Hbr | 45 | $362 | $8 |
| Oxycodone | 14 | $359 | $26 |
| Propranolol Hcl Er | 12 | $349 | $29 |
| Zolpidem | 42 | $339 | $8 |
| Pravastatin | 11 | $313 | $28 |
| Benazepril | 50 | $303 | $6 |
| Potassium Chloride | 14 | $279 | $20 |
| Metformin | 29 | $266 | $9 |
| Lisinopril-Hydrochlorothiazide | 42 | $260 | $6 |
| Furosemide | 33 | $239 | $7 |
| Cyclobenzaprine | 15 | $237 | $16 |
| Chlorthalidone | 11 | $222 | $20 |
| Irbesartan | 20 | $217 | $11 |
| Methadone | 12 | $217 | $18 |
| Fluoxetine | 18 | $212 | $12 |
| Finasteride | 11 | $210 | $19 |
| Meloxicam | 26 | $209 | $8 |
| Atenolol | 25 | $187 | $7 |
| Amitriptyline | 15 | $181 | $12 |
| Doxepin | 12 | $153 | $13 |
| Propranolol | 12 | $152 | $13 |
| Tramadol | 26 | $143 | $6 |
| Paroxetine | 11 | $142 | $13 |
| Sumatriptan | 13 | $140 | $11 |
| Prednisone | 24 | $140 | $6 |
| Prochlorperazine Maleate | 11 | $131 | $12 |
| Lorazepam | 37 | $125 | $3 |
| Clonazepam | 35 | $109 | $3 |
| Hydroxyzine | 27 | $94 | $3 |
| Amoxicillin-Clavulanate Potass | 11 | $94 | $9 |
| Cephalexin | 23 | $90 | $4 |
| Mupirocin | 12 | $88 | $7 |
| Nitrofurantoin Mono-Macro | 11 | $67 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $52 | $5 |
| Azithromycin | 16 | $23 | $1 |
| Paxlovid | 14 | $0 | $0 |
Year by year
| 2024 | 4,339 | 433 | 5% (226) | 10% | $335,278 |
| 2023 | 3,668 | 379 | 4% (153) | 12% | $319,961 |
| 2022 | 3,596 | 407 | 6% (226) | 11% | $296,756 |
| 2021 | 2,890 | 371 | 8% (223) | None | $172,963 |
| 2020 | 1,709 | 324 | 9% (157) | None | $68,449 |
| 2019 | 290 | 83 | None | None | $25,785 |
| 2018 | 82 | 30 | None | None | $6,538 |
| 2017 | 73 | 31 | None | None | $7,791 |
| 2016 | 21 | 11 | None | None | $1,687 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 79 drugs
| Ozempic | 34 | $35,050 | $1,031 |
| Trelegy Ellipta | 28 | $26,541 | $948 |
| Januvia | 16 | $16,866 | $1,054 |
| Eliquis | 21 | $13,462 | $641 |
| Flovent Hfa | 14 | $5,460 | $390 |
| Atorvastatin | 270 | $4,850 | $18 |
| Levothyroxine | 191 | $3,427 | $18 |
| Duloxetine | 42 | $2,795 | $67 |
| Hydrocodone-Acetaminophen | 91 | $2,725 | $30 |
| Albuterol Sulfate Hfa | 81 | $2,707 | $33 |
| Losartan | 112 | $2,464 | $22 |
| Gabapentin | 128 | $2,068 | $16 |
| Trazodone | 112 | $2,010 | $18 |
| Metformin Hcl Er | 68 | $1,734 | $26 |
| Estradiol | 19 | $1,513 | $80 |
| Famotidine | 25 | $1,502 | $60 |
| Synthroid | 12 | $1,455 | $121 |
| Celecoxib | 22 | $1,425 | $65 |
| Bupropion Xl | 37 | $1,380 | $37 |
| Tamsulosin | 51 | $1,248 | $24 |
| Amlodipine Besylate | 114 | $1,239 | $11 |
| Rosuvastatin | 27 | $1,195 | $44 |
| Benazepril | 49 | $1,158 | $24 |
| Omeprazole | 62 | $1,008 | $16 |
| Simvastatin | 67 | $1,000 | $15 |
| Valacyclovir | 22 | $933 | $42 |
| Lisinopril | 88 | $925 | $11 |
| Venlafaxine Hcl Er | 22 | $914 | $42 |
| Sertraline | 50 | $829 | $17 |
| Alendronate | 45 | $759 | $17 |
| Memantine | 14 | $758 | $54 |
| Pantoprazole | 28 | $735 | $26 |
| Fluticasone Propionate | 28 | $730 | $26 |
| Citalopram Hbr | 47 | $678 | $14 |
| Escitalopram | 36 | $656 | $18 |
| Propranolol Hcl Er | 14 | $655 | $47 |
| Lisinopril-Hydrochlorothiazide | 36 | $600 | $17 |
| Oxycodone-Acetaminophen | 19 | $598 | $31 |
| Liothyronine | 21 | $596 | $28 |
| Allopurinol | 35 | $571 | $16 |
| Diclofenac | 13 | $565 | $43 |
| Hydrochlorothiazide | 58 | $564 | $10 |
| Ropinirole | 12 | $562 | $47 |
| Baclofen | 16 | $556 | $35 |
| Clonazepam | 29 | $548 | $19 |
| Metoprolol | 26 | $544 | $21 |
| Oxybutynin Chloride | 15 | $528 | $35 |
| Esomeprazole Magnesium | 12 | $497 | $41 |
| Hydralazine | 15 | $470 | $31 |
| Montelukast | 24 | $468 | $19 |
| Hydroxyzine | 28 | $456 | $16 |
| Buspirone | 23 | $427 | $19 |
| Amitriptyline | 17 | $416 | $24 |
| Irbesartan | 18 | $399 | $22 |
| Metformin | 29 | $393 | $14 |
| Metoprolol | 20 | $377 | $19 |
| Atenolol | 17 | $364 | $21 |
| Pravastatin | 14 | $357 | $25 |
| Propranolol | 13 | $344 | $26 |
| Potassium Chloride | 13 | $336 | $26 |
| Ondansetron Odt | 19 | $327 | $17 |
| Clopidogrel | 11 | $321 | $29 |
| Furosemide | 47 | $301 | $6 |
| Losartan-Hydrochlorothiazide | 22 | $288 | $13 |
| Donepezil | 16 | $288 | $18 |
| Nitrofurantoin Mono-Macro | 16 | $272 | $17 |
| Alprazolam | 38 | $271 | $7 |
| Mirtazapine | 18 | $261 | $15 |
| Zolpidem | 28 | $251 | $9 |
| Paxlovid (Eua) | 25 | $249 | $10 |
| Tramadol | 23 | $228 | $10 |
| Cyclobenzaprine | 17 | $224 | $13 |
| Pramipexole Dihydrochloride | 11 | $183 | $17 |
| Lorazepam | 32 | $164 | $5 |
| Ibuprofen | 13 | $137 | $11 |
| Fluoxetine | 19 | $124 | $7 |
| Meloxicam | 18 | $93 | $5 |
| Cephalexin | 16 | $93 | $6 |
| Prednisone | 11 | $83 | $8 |
2022: 82 drugs
| Jardiance | 20 | $22,510 | $1,125 |
| Januvia | 19 | $20,853 | $1,098 |
| Rybelsus | 11 | $18,540 | $1,685 |
| Eliquis | 21 | $13,208 | $629 |
| Spiriva Handihaler | 13 | $12,220 | $940 |
| Myrbetriq | 19 | $11,482 | $604 |
| Trelegy Ellipta | 12 | $10,079 | $840 |
| Dulera | 11 | $4,491 | $408 |
| Levothyroxine | 174 | $3,715 | $21 |
| Atorvastatin | 266 | $3,649 | $14 |
| Hydrocodone-Acetaminophen | 137 | $3,234 | $24 |
| Albuterol Sulfate Hfa | 55 | $2,433 | $44 |
| Trazodone | 114 | $2,000 | $18 |
| Celecoxib | 27 | $1,895 | $70 |
| Metformin Hcl Er | 71 | $1,828 | $26 |
| Quetiapine | 20 | $1,689 | $84 |
| Propranolol Hcl Er | 15 | $1,632 | $109 |
| Duloxetine | 56 | $1,613 | $29 |
| Gabapentin | 121 | $1,607 | $13 |
| Esomeprazole Magnesium | 22 | $1,527 | $69 |
| Synthroid | 11 | $1,417 | $129 |
| Fluticasone-Salmeterol | 12 | $1,392 | $116 |
| Potassium Chloride | 17 | $1,289 | $76 |
| Losartan | 81 | $1,203 | $15 |
| Bupropion Xl | 39 | $1,187 | $30 |
| Valacyclovir | 32 | $1,143 | $36 |
| Liothyronine | 18 | $1,084 | $60 |
| Tamsulosin | 46 | $973 | $21 |
| Baclofen | 19 | $955 | $50 |
| Diclofenac | 12 | $934 | $78 |
| Benazepril | 48 | $929 | $19 |
| Citalopram Hbr | 42 | $885 | $21 |
| Estradiol | 18 | $876 | $49 |
| Irbesartan | 13 | $816 | $63 |
| Buspirone | 19 | $805 | $42 |
| Lisinopril | 98 | $804 | $8 |
| Allopurinol | 31 | $739 | $24 |
| Venlafaxine Hcl Er | 23 | $737 | $32 |
| Oxycodone | 14 | $733 | $52 |
| Escitalopram | 32 | $729 | $23 |
| Metoprolol | 23 | $679 | $30 |
| Fluticasone Propionate | 29 | $641 | $22 |
| Omeprazole | 48 | $618 | $13 |
| Amlodipine Besylate | 95 | $614 | $6 |
| Sertraline | 56 | $611 | $11 |
| Mirtazapine | 12 | $607 | $51 |
| Pantoprazole | 26 | $601 | $23 |
| Alprazolam | 57 | $583 | $10 |
| Lisinopril-Hydrochlorothiazide | 56 | $561 | $10 |
| Amitriptyline | 16 | $538 | $34 |
| Montelukast | 19 | $525 | $28 |
| Simvastatin | 54 | $517 | $10 |
| Clonazepam | 33 | $497 | $15 |
| Calcitonin-Salmon | 11 | $491 | $45 |
| Ropinirole | 14 | $457 | $33 |
| Famotidine | 17 | $447 | $26 |
| Alendronate | 38 | $441 | $12 |
| Zolpidem | 47 | $383 | $8 |
| Hydrochlorothiazide | 51 | $381 | $7 |
| Losartan-Hydrochlorothiazide | 28 | $374 | $13 |
| Methadone | 19 | $348 | $18 |
| Pravastatin | 17 | $328 | $19 |
| Tramadol | 29 | $307 | $11 |
| Paxlovid (Eua) | 30 | $289 | $10 |
| Rosuvastatin | 13 | $259 | $20 |
| Fluoxetine | 18 | $252 | $14 |
| Amoxicillin-Clavulanate Potass | 14 | $250 | $18 |
| Metformin | 28 | $244 | $9 |
| Hydralazine | 22 | $243 | $11 |
| Cyclobenzaprine | 18 | $222 | $12 |
| Cephalexin | 26 | $209 | $8 |
| Furosemide | 33 | $204 | $6 |
| Ciprofloxacin | 17 | $135 | $8 |
| Propranolol | 14 | $130 | $9 |
| Nitrofurantoin Mono-Macro | 11 | $111 | $10 |
| Oxycodone-Acetaminophen | 15 | $108 | $7 |
| Meloxicam | 14 | $106 | $8 |
| Ibuprofen | 15 | $88 | $6 |
| Metoprolol | 19 | $82 | $4 |
| Lorazepam | 29 | $73 | $3 |
| Temazepam | 16 | $61 | $4 |
| Diazepam | 11 | $34 | $3 |
2021: 63 drugs
| Spiriva | 12 | $9,083 | $757 |
| Jardiance | 12 | $6,809 | $567 |
| Wixela Inhub | 15 | $5,906 | $394 |
| Potassium Chloride | 31 | $4,009 | $129 |
| Hydrocodone-Acetaminophen | 144 | $3,775 | $26 |
| Atorvastatin | 220 | $3,239 | $15 |
| Levothyroxine | 125 | $3,114 | $25 |
| Fluticasone-Salmeterol | 15 | $2,237 | $149 |
| Albuterol Sulfate Hfa | 41 | $2,220 | $54 |
| Bupropion Xl | 49 | $1,975 | $40 |
| Gabapentin | 74 | $1,840 | $25 |
| Carbamazepine | 16 | $1,640 | $103 |
| Trazodone | 95 | $1,583 | $17 |
| Liothyronine | 20 | $1,463 | $73 |
| Oxycodone | 20 | $1,245 | $62 |
| Baclofen | 23 | $1,151 | $50 |
| Propranolol Hcl Er | 12 | $1,136 | $95 |
| Duloxetine | 32 | $1,135 | $35 |
| Venlafaxine Hcl Er | 19 | $1,113 | $59 |
| Metformin Hcl Er | 45 | $890 | $20 |
| Escitalopram | 38 | $853 | $22 |
| Losartan | 54 | $833 | $15 |
| Mirtazapine | 30 | $827 | $28 |
| Valacyclovir | 17 | $815 | $48 |
| Irbesartan | 12 | $787 | $66 |
| Amlodipine Besylate | 70 | $738 | $11 |
| Simvastatin | 47 | $597 | $13 |
| Fluticasone Propionate | 20 | $580 | $29 |
| Lisinopril | 67 | $542 | $8 |
| Citalopram Hbr | 32 | $523 | $16 |
| Lamotrigine | 16 | $520 | $33 |
| Omeprazole | 38 | $515 | $14 |
| Tamsulosin | 23 | $497 | $22 |
| Alprazolam | 49 | $454 | $9 |
| Sertraline | 42 | $454 | $11 |
| Benazepril | 45 | $442 | $10 |
| Metoprolol | 22 | $435 | $20 |
| Buspirone | 24 | $433 | $18 |
| Hydralazine | 17 | $409 | $24 |
| Allopurinol | 31 | $405 | $13 |
| Famotidine | 17 | $404 | $24 |
| Nortriptyline | 15 | $367 | $24 |
| Clonazepam | 34 | $344 | $10 |
| Pantoprazole | 21 | $343 | $16 |
| Lisinopril-Hydrochlorothiazide | 39 | $342 | $9 |
| Estradiol | 11 | $310 | $28 |
| Cyclobenzaprine | 47 | $309 | $7 |
| Zolpidem | 35 | $302 | $9 |
| Alendronate | 26 | $282 | $11 |
| Nadolol | 12 | $261 | $22 |
| Hydrochlorothiazide | 46 | $245 | $5 |
| Metformin | 21 | $242 | $12 |
| Cephalexin | 19 | $201 | $11 |
| Nitrofurantoin Mono-Macro | 12 | $197 | $16 |
| Furosemide | 31 | $180 | $6 |
| Ondansetron Odt | 11 | $178 | $16 |
| Fluoxetine | 16 | $173 | $11 |
| Clopidogrel | 11 | $148 | $13 |
| Oxycodone-Acetaminophen | 11 | $120 | $11 |
| Temazepam | 19 | $87 | $5 |
| Tramadol | 19 | $85 | $4 |
| Lorazepam | 18 | $78 | $4 |
| Ciprofloxacin | 12 | $46 | $4 |
2020: 48 drugs
| Hydrocodone-Acetaminophen | 95 | $1,750 | $18 |
| Gabapentin | 56 | $1,691 | $30 |
| Levothyroxine | 60 | $1,524 | $25 |
| Atorvastatin | 83 | $1,345 | $16 |
| Albuterol Sulfate Hfa | 31 | $1,258 | $41 |
| Bupropion Xl | 24 | $1,108 | $46 |
| Trazodone | 72 | $867 | $12 |
| Oxycodone | 19 | $735 | $39 |
| Ventolin Hfa | 12 | $696 | $58 |
| Baclofen | 24 | $653 | $27 |
| Famotidine | 23 | $611 | $27 |
| Levalbuterol Tartrate Hfa | 11 | $586 | $53 |
| Potassium Chloride | 13 | $543 | $42 |
| Fluticasone Propionate | 16 | $471 | $29 |
| Escitalopram | 24 | $448 | $19 |
| Lisinopril | 44 | $424 | $10 |
| Losartan | 24 | $389 | $16 |
| Metformin Hcl Er | 19 | $377 | $20 |
| Clonazepam | 29 | $351 | $12 |
| Citalopram Hbr | 28 | $340 | $12 |
| Tamsulosin | 16 | $336 | $21 |
| Oxycodone-Acetaminophen | 17 | $330 | $19 |
| Buspirone | 19 | $328 | $17 |
| Cyclobenzaprine | 42 | $317 | $8 |
| Duloxetine | 13 | $306 | $24 |
| Simvastatin | 21 | $294 | $14 |
| Lamotrigine | 11 | $285 | $26 |
| Mirtazapine | 17 | $281 | $17 |
| Zolpidem | 36 | $262 | $7 |
| Amlodipine Besylate | 31 | $262 | $8 |
| Lisinopril-Hydrochlorothiazide | 18 | $246 | $14 |
| Allopurinol | 11 | $235 | $21 |
| Alendronate | 15 | $213 | $14 |
| Sertraline | 22 | $210 | $10 |
| Benazepril | 15 | $173 | $12 |
| Hydrochlorothiazide | 24 | $156 | $7 |
| Cephalexin | 12 | $140 | $12 |
| Nitrofurantoin Mono-Macro | 11 | $133 | $12 |
| Omeprazole | 24 | $131 | $5 |
| Fluoxetine | 14 | $128 | $9 |
| Temazepam | 21 | $119 | $6 |
| Alprazolam | 25 | $118 | $5 |
| Metformin | 14 | $102 | $7 |
| Mupirocin | 11 | $94 | $9 |
| Azithromycin | 12 | $83 | $7 |
| Ciprofloxacin | 13 | $68 | $5 |
| Prednisone | 15 | $65 | $4 |
| Lorazepam | 16 | $58 | $4 |
2019: 5 drugs
| Atorvastatin | 18 | $367 | $20 |
| Metoprolol | 17 | $303 | $18 |
| Famotidine | 14 | $128 | $9 |
| Furosemide | 11 | $64 | $6 |
| Lisinopril | 11 | $63 | $6 |
Money from drug and device companies
$103 in 2025
| 2025 | 1 | 1 | None | $103 |
| 2021 | 1 | 1 | None | $104 |
| 2020 | 1 | 1 | None | $140 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $103 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-06-10 | Ozempic | $103 |
See earlier years (2021, 2020)
2021: $104
| Novo Nordisk | Rybelsus | $104 | 1 payment
|
2020: $140
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $140 | 1 payment
|
Professional record
- NPI
- 1336593755
- Licence
- CA A158545California A158545: Current · expires 2028-09-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 131 Stony Cir Ste 1600, Santa Rosa, CA, 95401
- NPI first listed
- 2016-04-21
- NPI last updated
- 2019-07-30
This is when the NPI record was last certified, not a medical board exam.